Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phagocytes | 2 | 2021 | 292 | 0.760 |
Why?
|
Phosphatidylcholines | 2 | 2019 | 403 | 0.720 |
Why?
|
Phospholipids | 2 | 2021 | 776 | 0.650 |
Why?
|
Lipopolysaccharides | 7 | 2021 | 2216 | 0.600 |
Why?
|
Dendritic Cells | 6 | 2021 | 2747 | 0.360 |
Why?
|
Toll-Like Receptors | 1 | 2014 | 583 | 0.350 |
Why?
|
Neutrophils | 1 | 2021 | 3776 | 0.300 |
Why?
|
Endothelial Cells | 1 | 2021 | 3584 | 0.300 |
Why?
|
Immunity | 1 | 2014 | 1002 | 0.300 |
Why?
|
Macrophages | 2 | 2019 | 5772 | 0.250 |
Why?
|
Inflammation | 3 | 2021 | 10850 | 0.230 |
Why?
|
Oxidation-Reduction | 2 | 2021 | 2218 | 0.230 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 434 | 0.150 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 502 | 0.140 |
Why?
|
Killer Cells, Natural | 2 | 2016 | 2210 | 0.130 |
Why?
|
Glycolysis | 1 | 2019 | 838 | 0.120 |
Why?
|
Inflammasomes | 2 | 2017 | 543 | 0.120 |
Why?
|
Receptors, Pattern Recognition | 1 | 2016 | 81 | 0.120 |
Why?
|
Adaptive Immunity | 2 | 2017 | 734 | 0.120 |
Why?
|
Caspases | 1 | 2016 | 880 | 0.100 |
Why?
|
Interleukin-15 | 1 | 2013 | 186 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2019 | 1149 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 517 | 0.100 |
Why?
|
Mice, Knockout | 4 | 2019 | 14448 | 0.090 |
Why?
|
Interleukin-1beta | 1 | 2016 | 1028 | 0.080 |
Why?
|
NFATC Transcription Factors | 1 | 2012 | 392 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1529 | 0.070 |
Why?
|
Edema | 1 | 2012 | 760 | 0.070 |
Why?
|
Calcium | 1 | 2021 | 5767 | 0.070 |
Why?
|
Animals | 9 | 2021 | 168764 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2016 | 3454 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2019 | 18973 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22332 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18293 | 0.050 |
Why?
|
Mice | 6 | 2021 | 81819 | 0.050 |
Why?
|
Skin | 1 | 2012 | 4489 | 0.040 |
Why?
|
Caspases, Initiator | 1 | 2016 | 31 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 23601 | 0.030 |
Why?
|
Interleukin-1 | 1 | 2017 | 1243 | 0.030 |
Why?
|
Endocytosis | 1 | 2017 | 951 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 586 | 0.020 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2012 | 105 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2012 | 456 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1679 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9550 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5020 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 594 | 0.020 |
Why?
|
Dinoprostone | 1 | 2012 | 591 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4260 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3051 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5747 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2081 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1167 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5881 | 0.020 |
Why?
|
Antigens | 1 | 2012 | 1438 | 0.020 |
Why?
|
Humans | 4 | 2021 | 765968 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5501 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2016 | 3081 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15543 | 0.010 |
Why?
|
Female | 2 | 2019 | 396112 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4913 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9525 | 0.010 |
Why?
|
Concepts
(64)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_